Tag Archives | active cellular immunotherapy

FED Rallies Market But Biotech Stocks Are Lagging…Update-1

Update-1 Stealth End of Month Rally Stops Biotech Slide IBB up 3.4% In July and up 1% on Last Day Stocks roared out of the box on Friday but could not hold and ended flat. NASDAQ Up 2.3% for July. Most biotech stocks were green and momentum players came back in to support their favorites: BLUE, JUNO, KITE, […]

Continue Reading 0

Biotech Stocks Shake Off Fears of Greek Crisis…Update-1… 7/8

Update 7/8/15  12:10p EDT Strange Day with Computer Networks NYSE exchange is down and trading halted- all orders are cancelled. However stocks are trading on other exchanges but at very low volume. United Airlines Grounding Ends after two hour disruption due to a router issue. Apparently no connection but….some other WEB sites are down as well. e.g. […]

Continue Reading 0

ASCO 2015 Biotech Movers Day Two: FCSC, JUNO, RXDX

Update-1 BLUE Drops 1.96% and 1.77% After Hours 6/3 In the bubbly CAR-T world bluebird bio (BLUE) and Celgene announced a deal for   for development of product candidates for B-cell maturation antigen (BMCA) utilizing bluebird bios’s gene therapy technology to modify a patient’s own T-Cells to target cancer cells. A $25M up-front payment was made but […]

Continue Reading 0

MOmentum Shift in BIOtech Today: XBI off 3.25%.. Update -1

Update Next Day…Green Screen in Biotech…1/16…Complete reversal all up XBI at $197.95 UP 3% AGIO up 3.6%, BLUE up 4.78%, JUNO up 12.4%, KITE up 10.2%, NLNK up 2.4%, PBYI up 9.4%, ZIOP up 1.76% Red Screen Day in Biotech NASDAQ 4584 down 1.18%    Euro down to $1.16     Gold at $1262 up […]

Continue Reading 0